SQUAMOUS CELL CARCINOMA
Clinical trials for SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer combo study halted early
Disease control TerminatedThis study tested a new drug called OC-001, given alone or with an immunotherapy drug (Avelumab), in people with advanced cancers that had spread. The goal was to check safety and how the drug moves through the body. The study was stopped early and involved 73 participants with v…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Early trial tests new drug combo for tough head & neck cancers
Disease control TerminatedThis early-stage study aimed to find a safe dose for combining a new immunotherapy drug (pembrolizumab) with standard chemotherapy and radiation in patients with advanced head and neck cancer. The main goal was to check if the combination caused acceptable side effects, especiall…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Apr 09, 2026 19:34 UTC
-
Scientists hunt for DNA markers to forecast lung cancer's next move
Knowledge-focused TerminatedThis study aimed to find genetic changes that could predict how a type of lung cancer (squamous cell carcinoma) progresses. Researchers planned to collect tissue and blood samples from 200 people with this cancer. The study was stopped early and only 22 people took part, so the r…
Matched conditions: SQUAMOUS CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 00:51 UTC